128
CONCLUSIONS: The risk of drug-induced rhabdomyolysis due to the potential interaction between lovastatin and azithromycin or clarithromycin should be considered before the concomitant use of these agents.
 ( adverse event: due ,  rhabdomyolysis: Effect, lovastatin: Treatment, azithromycin: Treatment, clarithromycin: Treatment, lovastatin: Treatment.Drug, azithromycin: Treatment.Drug, clarithromycin: Treatment.Drug, lovastatin: Combination.Drug, azithromycin: Combination.Drug, clarithromycin: Combination.Drug) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: due ,  rhabdomyolysis: Effect, lovastatin: Treatment, azithromycin: Treatment, clarithromycin: Treatment, lovastatin: Treatment.Drug, azithromycin: Treatment.Drug, clarithromycin: Treatment.Drug, lovastatin: Combination.Drug, azithromycin: Combination.Drug, clarithromycin: Combination.Drug) 